Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SEROPHENE

CLOMIPHENE CITRATE

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SEROPHENE is listed in Drugs@FDA under application 018361 (NDA).

Marketing status: Discontinued Active ingredient CLOMIPHENE CITRATE Form and strength TABLET;ORAL - 50MG Sponsor EMD SERONO Submission history Latest submission status date: 2003-07-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview SEROPHENE is listed in Drugs@FDA under application 018361 (NDA). Marketing status: Discontinued Active ingredient CLOMIPHENE CITRATE Form and strength TABLET;ORAL - 50MG Sponsor EMD SERONO Submission history Latest submission status date: 2003-07-31 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
SEROPHENE (CLOMIPHENE CITRATE) | Drug Monograph | MedicHelpline